000			02077 a2200577 4500
005			20250516093655.0
264		0	_c20120928
008			201209s 0 0 eng d
022			_a1473-5741
024	7		_a10.1097/CAD.0b013e3283534d3e _2doi
040			_aNLM _beng _cNLM
100	1		_aGil, Miguel J
245	0	0	_aBevacizumab plus irinotecan in recurrent malignant glioma shows high overall survival in a multicenter retrospective pooled series of the Spanish Neuro-Oncology Research Group (GEINO). _h[electronic resource]
260			_bAnti-cancer drugs _cJul 2012
300			_a659-65 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal, Humanized _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBevacizumab
650	0	4	_aCamptothecin _xadministration & dosage
650	0	4	_aCentral Nervous System Neoplasms _xdrug therapy
650	0	4	_aCompassionate Use Trials
650	0	4	_aDacarbazine _xanalogs & derivatives
650	0	4	_aDisease Progression
650	0	4	_aGlioma _xdrug therapy
650	0	4	_aHumans
650	0	4	_aIrinotecan
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Recurrence, Local _xdrug therapy
650	0	4	_aRetrospective Studies
650	0	4	_aTemozolomide
650	0	4	_aTreatment Outcome
700	1		_ade Las Peñas, Ramón
700	1		_aReynés, Gaspar
700	1		_aBalañá, Carme
700	1		_aPeréz-Segura, Pedro
700	1		_aGarcía-Velasco, Adelaida
700	1		_aMesia, Carlos
700	1		_aGallego, Oscar
700	1		_aFernández-Chacón, Concepción
700	1		_aMartínez-García, María
700	1		_aHerrero, Ana
700	1		_aAndrés, Raquel
700	1		_aBenavides, Manuel
700	1		_aQuintanar, Teresa
700	1		_aPérez-Martin, Xavier
773	0		_tAnti-cancer drugs _gvol. 23 _gno. 6 _gp. 659-65
856	4	0	_uhttps://doi.org/10.1097/CAD.0b013e3283534d3e _zAvailable from publisher's website
999			_c21814370 _d21814370